Cargando…
p53-Bad* in a Hepatocellular Carcinoma Mouse Model
Recent advances in liver cancer treatments have not changed the fact that the majority of patients will not survive the disease. In order to advance future liver cancer treatments, this work presents an exploration of various iterations of the liver cancer specific AFP promoter as well as the gene c...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cold Spring Harbor Laboratory
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327098/ https://www.ncbi.nlm.nih.gov/pubmed/37425886 http://dx.doi.org/10.1101/2023.06.29.547129 |